Top Story

Laparoscopic colectomy reduces health care utilization, costs

March 27, 2015

Laparoscopic colectomy significantly reduced short- and long-term health care utilization and costs compared with open colectomy, according to recent study data.

“We found that the use of minimally invasive laparoscopic approaches in a select group of patients undergoing colectomy procedures resulted in significantly lower health care costs and resource utilization compared with open surgical approaches,” Conor P. Delaney, MD, PhD, from University Hospitals Case Medical Center in Cleveland, said in a press release. “This may expand access and lower the cost of patient care in the long term.”

In the Journals

Anti-HCV seropositivity not associated with metabolic syndrome

March 27, 2015
Anti-hepatitis C virus infection seropositivity was not associated with metabolic syndrome among Taiwanese adults, regardless of age, gender and fibrosis, according to…
Jennifer Dotson, MD

7 recent developments in Crohn's disease

March 27, 2015
Crohn’s disease has been a hot topic recently, with an abundance of data being published in the journals this month. Here is a recap of the most trafficked news on…
Breaking News

Senate adjourns without voting on bill to repeal sustainable growth rate

March 27, 2015
The U.S. Senate left for its 2-week spring break without voting on a bill that repeals the sustainable growth rate, leaving physicians to face a 21% payment cut if…

Japan approves Sovaldi for HCV genotype 2

March 27, 2015
The Japanese Ministry of Health, Labour and Welfare has approved Sovaldi to suppress viremia in patients with chronic hepatitis C virus genotype 2 infection, with or…
More News Headlines »
CME
cover

HCV Council 2014 Recap Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape

This activity is supported by an educational grant from AbbVie Inc., Gilead Sciences, Inc., and Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Meeting News Coverage Video
thumbnail for video 4131516814001

'The time has come' for individualized treatment for obese, overweight patients

March 24, 2015
SAN FRANCISCO — Michael Camilleri, MD, AGAF, from the Mayo Clinic in Rochester, Minn., discusses his presentation…
More »
CME
HCV Council 2014 Revisited at AASLD - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape

HCV Council 2014 Revisited at AASLD - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape

This activity is supported by an educational grant from AbbVie Inc., Gilead Sciences, Inc., and Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
morganatic-roan
morganatic-roan